Show simple item record

dc.contributor.authorKimber Richteren_US
dc.contributor.authorJulia Arnstenen_US
dc.date.accessioned2009-05-05T16:16:06Z
dc.date.available2009-05-05T16:16:06Z
dc.date.issued2007-04-03en_US
dc.identifier.citationKimber Richter;Julia Arnsten: A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy 2006, 1(1):23.en_US
dc.identifier.urihttp://hdl.handle.net/2271/618en_US
dc.description.abstractMost persons in drug treatment smoke cigarettes. Until drug treatment facilities systematically treat their patients' tobacco use, millions will flow through the drug treatment system, overcome their primary drug of abuse, but die prematurely from tobacco-related illnesses. This paper reviews the literature on the health benefits of quitting smoking for drug treatment patients, whether smoking causes relapse to other drug or alcohol abuse, the treatment of tobacco dependence, and good and bad times for quitting smoking among drug treatment patients. It also presents a conceptual model and recommendations for treating tobacco in substance abuse treatment, and provides references to internet and paper-copy tools and information for treating tobacco dependence. At present, research on tobacco treatment in drug treatment is in its infancy. Although few drug treatment programs currently offer formal services, many more will likely begin to treat nicotine dependence as external forces and patient demand for these services increases. In the absence of clear guidelines and attention to quality of care, drug treatment programs may adopt smoking cessation services based on cost, convenience, or selection criteria other than efficacy. Because research in this field is relatively new, substance abuse treatment professionals should adhere to the standards of care for the general population, but be prepared to update their practices with emerging interventions that have proven to be effective for patients in drug treatment.en_US
dc.languageenen_US
dc.language.isoen_USen_US
dc.publisherBioMedCentralen_US
dc.relation.isversionofhttp://www.substanceabusepolicy.com/content/1/1/23en_US
dc.relation.hasversionhttp://www.biomedcentral.com/content/pdf/1747-597X-1-23.pdfen_US
dc.rightsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0en_US
dc.subject.meshAnimalsen_US
dc.subject.meshBiomedical Researchen_US
dc.subject.meshDisease Models, Animalen_US
dc.subject.meshEvolutionen_US
dc.subject.meshGenetic Variationen_US
dc.subject.meshHumansen_US
dc.subject.meshMedicineen_US
dc.subject.meshPhilosophy, Medicalen_US
dc.subject.meshSelection (Genetics)en_US
dc.subject.meshSpecies Specificityen_US
dc.titleA rationale and model for addressing tobacco dependence in substance abuse treatmenten_US
dc.typeArticleen_US
dc.identifier.doi10.1186/1747-597X-1-23en_US
dc.identifier.pmid17407602en_US
dc.rights.accessrightsopenAccessen_US
dc.date.captured2009-04-27en_US


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.